Abstract | BACKGROUND: METHODS AND RESULTS: CONCLUSIONS: In this cohort, procainamide achieved greater success compared with amiodarone in the management of recurrent SVT without statistically significant differences in adverse event frequency.
|
Authors | Philip M Chang, Michael J Silka, David Y Moromisato, Yaniv Bar-Cohen |
Journal | Circulation. Arrhythmia and electrophysiology
(Circ Arrhythm Electrophysiol)
Vol. 3
Issue 2
Pg. 134-40
(Apr 2010)
ISSN: 1941-3084 [Electronic] United States |
PMID | 20194798
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Anti-Arrhythmia Agents
- Procainamide
- Amiodarone
|
Topics |
- Acute Disease
- Adolescent
- Amiodarone
(administration & dosage, adverse effects)
- Anti-Arrhythmia Agents
(administration & dosage, adverse effects)
- Child
- Child, Preschool
- Female
- Heart Defects, Congenital
(complications)
- Humans
- Infant
- Infant, Newborn
- Injections, Intravenous
- Male
- Practice Guidelines as Topic
- Procainamide
(administration & dosage, adverse effects)
- Retrospective Studies
- Secondary Prevention
- Tachycardia, Supraventricular
(complications, drug therapy)
- Treatment Outcome
- Young Adult
|